Home
Reels
Grupuri
Pagini
Arata mai mult
Grupuri Pagini Events Blogs Funding
Conecteaza-te Inscrie-te
Night Mode
Autologous vs. Allogeneic: The CAR T Manufacturing Race
The promise of CAR T therapy is constrained by a manufacturing challenge: creating personalized treatments at scale is complex, time-consuming, and expensive. Autologous therapy—using the patient's own cells—requires a bespoke manufacturing process for each patient, with vein-to-vein times that can delay treatment. Allogeneic therapy—using donor cells—offers the...
0 Commentarii ·0 Distribuiri ·21 Views ·0 previzualizare
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!